title: The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome.
authors.forename: Theodore E
authors.initials: TE
authors.lastname: Warkentin
authors.forename: Anup K
authors.initials: AK
authors.lastname: Chakraborty
authors.forename: Jo-Ann I
authors.initials: JA
authors.lastname: Sheppard
authors.forename: Danielle K
authors.initials: DK
authors.lastname: Griffin
mesh_terms: D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives; D005260:Female; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects* / Q000737:chemistry; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods; D007249:Inflammation; D010875:Pipecolic Acids / Q000627:therapeutic use; D010978:Platelet Factor 4 / Q000737:chemistry; D011134:Polysaccharides / Q000009:adverse effects / Q000097:blood*; D013449:Sulfonamides; D013577:Syndrome; D013921:Thrombocytopenia / Q000139:chemically induced*; D016896:Treatment Outcome
chemical_list: D010875:Pipecolic Acids; D011134:Polysaccharides; D013449:Sulfonamides; D010978:Platelet Factor 4; D006493:Heparin; D001120:Arginine; C031942:argatroban; D000077425:Fondaparinux